Observational Study of Baska Mask, a New Supraglottic Airway Device in Children
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
-
Galway, Ireland
- Galway University Hospitals
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- consent
- BMI 15-35
- weight over 30kg or age 8-16 yrs
- non-urgent surgery of planned duration up to 2 hrs
Exclusion Criteria:
- neck pathology
- previous or anticipated problems with the upper GI or upper airway
- increased risk of gastric aspiration
- expected difficult airway
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Baska mask
|
Use of Baska mask as a supraglottic airway during general anesthesia
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Device insertion success rate
Time Frame: within 30 minutes of induction of general anesthesia
|
within 30 minutes of induction of general anesthesia
|
|
|
device airway leak pressure
Time Frame: within 10 minutes of successful device placement
|
the airway l;eak pressure is defined as the plateau airway pressure measured while the patient is apnoeic with the APL valve of the anaesthetic machine set to 35 cm H2O and the fresh gas flow set to 6 L/min
|
within 10 minutes of successful device placement
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
airway stability
Time Frame: within 30 minutes of device placement
|
the tidal volumes will be measured in different head positions and the leak fractions calculated.
|
within 30 minutes of device placement
|
|
ease of device placement
Time Frame: within 30 minutes of induction of general anesthesia
|
the ease of device placement will be evaluated by Visual Analogue Scale
|
within 30 minutes of induction of general anesthesia
|
|
complications during the anesthetic
Time Frame: from the start of device insertion untill discharge from recovery, an expected average of 2 hours
|
complications that may be related to the device use will be monitored including but not limited to desaturation episodes, laryngospasm, loss of airway, need to switch ot alternative device, blood staining on mask removal sore throat, dysphonia, dysphagia
|
from the start of device insertion untill discharge from recovery, an expected average of 2 hours
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Michael Scully, FFARCSI, UCHG
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- C.A.657
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.